Published in J Agric Food Chem on October 15, 2013
Japanese traditional dietary fungus koji Aspergillus oryzae functions as a prebiotic for Blautia coccoides through glycosylceramide: Japanese dietary fungus koji is a new prebiotic. Springerplus (2016) 1.39
Is lactate an undervalued functional component of fermented food products? Front Microbiol (2015) 0.81
Selective Manipulation of the Gut Microbiota Improves Immune Status in Vertebrates. Front Immunol (2015) 0.81
Prebiotic administration normalizes lipopolysaccharide (LPS)-induced anxiety and cortical 5-HT2A receptor and IL1-β levels in male mice. Brain Behav Immun (2016) 0.80
Alterations of the gut microbiome and metabolome in alcoholic liver disease. World J Gastrointest Pathophysiol (2014) 0.79
HUIEC, Human intestinal epithelial cell line with differentiated properties: process of isolation and characterisation. Wien Klin Wochenschr (2015) 0.76
Local Treatment with Lactate Prevents Intestinal Inflammation in the TNBS-Induced Colitis Model. Front Immunol (2016) 0.75
Polydextrose: Physiological Function, and Effects on Health. Nutrients (2016) 0.75
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest (2008) 6.17
Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol (2004) 3.41
Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol (2006) 3.01
A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology (2004) 2.75
Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease. J Gastroenterol Hepatol (2013) 1.80
IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol (2002) 1.64
Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. J Gastroenterol (2010) 1.58
Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts: role of interleukin-17. J Gastroenterol (2003) 1.55
Germinated barley foodstuff, a prebiotic product, ameliorates inflammation of colitis through modulation of the enteric environment. J Gastroenterol (2003) 1.51
Butyrate blocks interferon-gamma-inducible protein-10 release in human intestinal subepithelial myofibroblasts. J Gastroenterol (2005) 1.49
Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance. J Gastroenterol Hepatol (2007) 1.47
Suppression of interleukin-1beta- and tumor necrosis factor-alpha-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis. J Gastroenterol (2004) 1.46
Prebiotic treatment in experimental colitis reduces the risk of colitic cancer. J Gastroenterol Hepatol (2011) 1.43
Immunohistochemical analysis of cell cycle-regulating-protein (p21, p27, and Ki-67) expression in gastroesophageal reflux disease. J Gastroenterol (2002) 1.42
IL-6 secretion by human pancreatic periacinar myofibroblasts in response to inflammatory mediators. J Immunol (2002) 1.38
Novel biodegradable stents for benign esophageal strictures following endoscopic submucosal dissection. Dig Dis Sci (2007) 1.37
Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial. J Gastroenterol (2002) 1.30
Fecal calprotectin is a useful marker for disease activity in pediatric patients with inflammatory bowel disease. Dig Dis Sci (2011) 1.30
An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment. Am J Gastroenterol (2009) 1.24
Usefulness of biodegradable stents constructed of poly-l-lactic acid monofilaments in patients with benign esophageal stenosis. World J Gastroenterol (2007) 1.22
Interleukin-32 expression in the pancreas. J Biol Chem (2009) 1.14
The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice. Oncol Rep (2006) 1.13
Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease. Curr Pharm Des (2009) 1.12
Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease. Digestion (2016) 1.09
Interleukin-5 participates in the pathogenesis of ileitis in SAMP1/Yit mice. Eur J Immunol (2004) 1.09
Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis. Inflamm Bowel Dis (2007) 1.09
Germinated barley foodstuff prolongs remission in patients with ulcerative colitis. Int J Mol Med (2004) 1.08
Newly developed biodegradable stents for benign gastrointestinal tract stenoses: a preliminary clinical trial. Digestion (2007) 1.07
Inflammatory responses induced by interleukin-17 family members in human colonic subepithelial myofibroblasts. J Gastroenterol (2007) 1.07
Regulation of IL-11 expression in intestinal myofibroblasts: role of c-Jun AP-1- and MAPK-dependent pathways. Am J Physiol Gastrointest Liver Physiol (2003) 1.04
Regulation of amphiregulin and epiregulin expression in human colonic subepithelial myofibroblasts. Int J Mol Med (2006) 1.02
Modification of intestinal flora in the treatment of inflammatory bowel disease. Curr Pharm Des (2003) 1.00
The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease. J Gastroenterol (2010) 1.00
Neutralization of complement component C5 ameliorates the development of dextran sulfate sodium (DSS)-colitis in mice. J Clin Biochem Nutr (2012) 0.99
Clinical utility of newly developed immunoassays for serum concentrations of adalimumab and anti-adalimumab antibodies in patients with Crohn's disease. J Gastroenterol (2013) 0.99
Energy metabolism in Japanese patients with Crohn's disease. J Clin Biochem Nutr (2009) 0.97
Interleukin-33 suppresses Notch ligand expression and prevents goblet cell depletion in dextran sulfate sodium-induced colitis. Int J Mol Med (2011) 0.97
Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-32alpha induction in human pancreatic periacinar myofibroblasts. Am J Physiol Gastrointest Liver Physiol (2008) 0.96
Sub-classification of type VI pit patterns in colorectal tumors: relation to the depth of tumor invasion. Int J Oncol (2008) 0.95
Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: multi-center open trial. Int J Mol Med (2003) 0.95
Development of a new immunoassay for the accurate determination of anti-infliximab antibodies in inflammatory bowel disease. J Gastroenterol (2011) 0.94
Relationship between serum infliximab trough levels and endoscopic activities in patients with Crohn's disease under scheduled maintenance treatment. J Gastroenterol (2013) 0.94
Eubacterium limosum ameliorates experimental colitis and metabolite of microbe attenuates colonic inflammatory action with increase of mucosal integrity. World J Gastroenterol (2006) 0.94
The free radical scavenger edaravone suppresses experimental dextran sulfate sodium-induced colitis in rats. Int J Mol Med (2003) 0.93
Bile acid modulates transepithelial permeability via the generation of reactive oxygen species in the Caco-2 cell line. Free Radic Biol Med (2005) 0.93
Inflixmab as a possible treatment for the hemorrhagic type of Crohn's disease. J Gastroenterol (2004) 0.93
Hepatic reactive lymphoid hyperplasia in a patient with primary biliary cirrhosis. World J Hepatol (2010) 0.92
N-butyl-2-cyanoacrylate (histoacryl) glue in the right atrium after endoscopic injection for a ruptured duodenal varix: complication of histoacryl injection. Dig Endosc (2012) 0.92
Energy expenditure in Japanese patients with severe or moderate ulcerative colitis. J Clin Biochem Nutr (2010) 0.92
Expression of interleukin 1-like cytokine interleukin 33 and its receptor complex (ST2L and IL1RAcP) in human pancreatic myofibroblasts. Gut (2009) 0.92
Lack of macrophage migration inhibitory factor suppresses innate immune response in murine dextran sulfate sodium-induced colitis. Scand J Gastroenterol (2008) 0.91
Polymorphism of the inosine triphosphate pyrophosphatase gene predicts ribavirin-induced anemia in chronic hepatitis C patients. Mol Med Rep (2011) 0.91
Overview of the role of macrophage migration inhibitory factor (MIF) in inflammatory bowel disease. Curr Pharm Des (2009) 0.91
Non-Epstein-Barr virus associated lymphoepithelioma-like carcinoma of the inferior common bile duct. World J Gastrointest Oncol (2011) 0.91
Hepatocellular carcinoma occurring in a Crohn's disease patient. World J Gastroenterol (2010) 0.91
New prebiotics from rice bran ameliorate inflammation in murine colitis models through the modulation of intestinal homeostasis and the mucosal immune system. Scand J Gastroenterol (2010) 0.90
Curcumin prevents the development of dextran sulfate Sodium (DSS)-induced experimental colitis. Dig Dis Sci (2007) 0.90
Gastric inflammatory fibroid polyp treated with Helicobacter pylori eradication therapy. Intern Med (2003) 0.89
Clinical trial: Effects of an oral preparation of mesalazine at 4 g/day on moderately active ulcerative colitis. A phase III parallel-dosing study. J Gastroenterol (2010) 0.89
Endoscopic retrieval of migrated plastic stent into bile duct or pancreatic pseudocyst. Dig Endosc (2009) 0.89
Endoscopic discrimination of sessile serrated adenomas from other serrated lesions. Oncol Lett (2011) 0.89
A new therapeutic approach using a schizophyllan-based drug delivery system for inflammatory bowel disease. Mol Ther (2012) 0.89
Depletion of endothelial progenitor cells in the peripheral blood of patients with ulcerative colitis. Int J Mol Med (2007) 0.88
Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) recognizes a novel ligand, Mac-2-binding protein, characteristically expressed on human colorectal carcinomas. J Biol Chem (2011) 0.88
Development of dextran sulfate sodium-induced colitis is aggravated in mice genetically deficient for complement C5. Int J Mol Med (2005) 0.88
Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis. Ther Apher Dial (2005) 0.87
Interleukin-31 stimulates production of inflammatory mediators from human colonic subepithelial myofibroblasts. Int J Mol Med (2007) 0.87
Analysis of thiopurine S-methyltransferase genotypes in Japanese patients with inflammatory bowel disease. Intern Med (2008) 0.87
A new prebiotic from germinated barley for nutraceutical treatment of ulcerative colitis. J Gastroenterol Hepatol (2002) 0.87
Interleukin 22 receptor 1 expression in pancreas islets. Pancreas (2008) 0.87
Clostridium butyricum, a probiotic derivative, suppresses dextran sulfate sodium-induced experimental colitis in rats. Int J Mol Med (2004) 0.87
The membrane-bound mucin Muc1 regulates T helper 17-cell responses and colitis in mice. Gastroenterology (2011) 0.86
Amphiregulin and epiregulin expression in neoplastic and inflammatory lesions in the colon. Oncol Rep (2008) 0.86
Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel Disease. Inflamm Bowel Dis (2016) 0.85
Usefulness of bispectral monitoring of conscious sedation during endoscopic mucosal dissection. World J Gastroenterol (2009) 0.85
Prebiotic treatment of experimental colitis with germinated barley foodstuff: a comparison with probiotic or antibiotic treatment. Int J Mol Med (2002) 0.85
Tacrolimus (FK506) suppresses TNF-α-induced CCL2 (MCP-1) and CXCL10 (IP-10) expression via the inhibition of p38 MAP kinase activation in human colonic myofibroblasts. Int J Mol Med (2012) 0.85
Changes of energy metabolism, nutritional status and serum cytokine levels in patients with Crohn's disease after anti-tumor necrosis factor-α therapy. J Clin Biochem Nutr (2013) 0.84
Interleukin-1beta and tumor necrosis factor-alpha upregulate interleukin-23 subunit p19 gene expression in human colonic subepithelial myofibroblasts. Int J Mol Med (2005) 0.84
Stem cell factor expressed in human gastric mucosa in relation to mast cell increase in Helicobacter pylori-infected gastritis. Dig Dis Sci (2002) 0.84
Factors affecting the efficacy of cyclosporin A therapy for refractory ulcerative colitis. J Gastroenterol Hepatol (2010) 0.84
Endoscopic submucosal dissection combined with the placement of biodegradable stents for recurrent esophageal cancer after chemoradiotherapy. J Gastrointest Cancer (2012) 0.83
Magnifying endoscopy with narrow-band imaging in the differential diagnosis of gastric adenoma and carcinoma and identification of a simple indicator. J Gastrointestin Liver Dis (2012) 0.83
Dextran sulfate sodium administered orally is depolymerized in the stomach and induces cell cycle arrest plus apoptosis in the colon in early mouse colitis. Oncol Rep (2012) 0.83
Interleukin-17 and lipopolysaccharides synergistically induce cyclooxygenase-2 expression in human intestinal myofibroblasts. J Gastroenterol Hepatol (2005) 0.83
Interleukin-32α expression in human colonic subepithelial myofibroblasts. Int J Mol Med (2010) 0.83
Successful treatment of rectal ulcers in a patient with systemic lupus erythematosus using corticosteroids and tacrolimus. Mod Rheumatol (2014) 0.83
Cellobiose Prevents the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental Colitis. J Clin Biochem Nutr (2010) 0.82